Adaptimmune Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $91 | 700 | 0.13 |
| 2025-06-30 | $2.6k | 11k | 0.24 |
| 2025-03-31 | $4.3k | 22k | 0.20 |
| 2024-12-31 | $11k | 20k | 0.54 |
| 2024-09-30 | $4.4k | 4.7k | 0.95 |
| 2023-09-30 | $6.3k | 8.0k | 0.78 |
| 2023-06-30 | $15k | 16k | 0.93 |
| 2023-03-31 | $13k | 12k | 1.07 |
| 2022-12-31 | $12k | 8.0k | 1.50 |
| 2022-09-30 | $28k | 30k | 0.94 |
| 2022-06-30 | $50k | 29k | 1.69 |
| 2022-03-31 | $10k | 4.7k | 2.12 |
| 2021-12-31 | $0 | 5.9k | 0.00 |
| 2021-09-30 | $47k | 9.1k | 5.16 |
| 2021-06-30 | $15k | 4.2k | 3.42 |
| 2021-03-31 | $30k | 5.7k | 5.29 |
| 2020-12-31 | $14k | 2.7k | 5.22 |
| 2020-03-31 | $26k | 9.6k | 2.71 |
| 2019-12-31 | $0 | 162 | 0.00 |
| 2019-09-30 | $27k | 22k | 1.26 |
| 2019-06-30 | $0 | 100 | 0.00 |
| 2019-03-31 | $27k | 6.4k | 4.23 |
| 2018-09-30 | $7.0k | 496 | 14.11 |
| 2018-06-30 | $23k | 2.0k | 11.73 |
| 2018-03-31 | $37k | 3.3k | 11.14 |
| 2017-12-31 | $32k | 4.8k | 6.64 |
| 2017-06-30 | $16k | 3.7k | 4.37 |
| 2016-12-31 | $999 | 288 | 3.47 |
| 2016-09-30 | $11k | 1.5k | 7.16 |
| 2016-06-30 | $2.0k | 208 | 9.62 |